These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 19665973)

  • 1. The selectivity of receptor tyrosine kinase signaling is controlled by a secondary SH2 domain binding site.
    Bae JH; Lew ED; Yuzawa S; Tomé F; Lax I; Schlessinger J
    Cell; 2009 Aug; 138(3):514-24. PubMed ID: 19665973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors.
    Ong SH; Guy GR; Hadari YR; Laks S; Gotoh N; Schlessinger J; Lax I
    Mol Cell Biol; 2000 Feb; 20(3):979-89. PubMed ID: 10629055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptide.
    Narula SS; Yuan RW; Adams SE; Green OM; Green J; Philips TB; Zydowsky LD; Botfield MC; Hatada M; Laird ER
    Structure; 1995 Oct; 3(10):1061-73. PubMed ID: 8590001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.
    Eck MJ; Shoelson SE; Harrison SC
    Nature; 1993 Mar; 362(6415):87-91. PubMed ID: 7680435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of electrostatic interactions in SH2 domain recognition: salt-dependence of tyrosyl-phosphorylated peptide binding to the tandem SH2 domain of the Syk kinase and the single SH2 domain of the Src kinase.
    Grucza RA; Bradshaw JM; Mitaxov V; Waksman G
    Biochemistry; 2000 Aug; 39(33):10072-81. PubMed ID: 10955995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
    van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
    Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal transduction pathways triggered by fibroblast growth factor receptor 1 expressed in Xenopus laevis oocytes after fibroblast growth factor 1 addition. Role of Grb2, phosphatidylinositol 3-kinase, Src tyrosine kinase, and phospholipase Cgamma.
    Browaeys-Poly E; Cailliau K; Vilain JP
    Eur J Biochem; 2000 Oct; 267(20):6256-63. PubMed ID: 11012680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SH-PTP2/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth factor beta-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptides.
    Case RD; Piccione E; Wolf G; Benett AM; Lechleider RJ; Neel BG; Shoelson SE
    J Biol Chem; 1994 Apr; 269(14):10467-74. PubMed ID: 8144631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
    Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA
    Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of the C-terminal SH2 domain of the p85alpha regulatory subunit of phosphoinositide 3-kinase: an SH2 domain mimicking its own substrate.
    Hoedemaeker FJ; Siegal G; Roe SM; Driscoll PC; Abrahams JP
    J Mol Biol; 1999 Oct; 292(4):763-70. PubMed ID: 10525402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The src homology 2 and phosphotyrosine binding domains of the ShcC adaptor protein function as inhibitors of mitogenic signaling by the epidermal growth factor receptor.
    O'Bryan JP; Lambert QT; Der CJ
    J Biol Chem; 1998 Aug; 273(32):20431-7. PubMed ID: 9685397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective Targeting of SH2 Domain-Phosphotyrosine Interactions of Src Family Tyrosine Kinases with Monobodies.
    Kükenshöner T; Schmit NE; Bouda E; Sha F; Pojer F; Koide A; Seeliger M; Koide S; Hantschel O
    J Mol Biol; 2017 May; 429(9):1364-1380. PubMed ID: 28347651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase.
    Lee CH; Kominos D; Jacques S; Margolis B; Schlessinger J; Shoelson SE; Kuriyan J
    Structure; 1994 May; 2(5):423-38. PubMed ID: 7521735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The specificity of the N-terminal SH2 domain of SHP-2 is modified by a single point mutation.
    Huyer G; Ramachandran C
    Biochemistry; 1998 Mar; 37(9):2741-7. PubMed ID: 9485424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the roles of SH2 domain-containing proteins in T-lymphocyte activation by using dominant negative SH2 domains.
    Northrop JP; Pustelnik MJ; Lu AT; Grove JR
    Mol Cell Biol; 1996 May; 16(5):2255-63. PubMed ID: 8628292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of p62, a multifunctional SH2- and SH3-domain-binding protein, with src family tyrosine kinases, Grb2, and phospholipase C gamma-1.
    Richard S; Yu D; Blumer KJ; Hausladen D; Olszowy MW; Connelly PA; Shaw AS
    Mol Cell Biol; 1995 Jan; 15(1):186-97. PubMed ID: 7799925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The N-terminal SH2 domains of Syk and ZAP-70 mediate phosphotyrosine-independent binding to integrin beta cytoplasmic domains.
    Woodside DG; Obergfell A; Talapatra A; Calderwood DA; Shattil SJ; Ginsberg MH
    J Biol Chem; 2002 Oct; 277(42):39401-8. PubMed ID: 12171941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affinity, specificity, and kinetics of the interaction of the SHC phosphotyrosine binding domain with asparagine-X-X-phosphotyrosine motifs of growth factor receptors.
    Laminet AA; Apell G; Conroy L; Kavanaugh WM
    J Biol Chem; 1996 Jan; 271(1):264-9. PubMed ID: 8550571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SH2 domains exhibit high-affinity binding to tyrosine-phosphorylated peptides yet also exhibit rapid dissociation and exchange.
    Felder S; Zhou M; Hu P; Ureña J; Ullrich A; Chaudhuri M; White M; Shoelson SE; Schlessinger J
    Mol Cell Biol; 1993 Mar; 13(3):1449-55. PubMed ID: 7680095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational investigation of the specificity determining region of the Src SH2 domain.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 2000 Jun; 299(2):521-35. PubMed ID: 10860756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.